Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2000
12/12/2000US6159970 Enzyme inhibitors
12/12/2000US6159964 Vitronectin receptor antagonists
12/12/2000US6159962 3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same
12/12/2000US6159960 Steroid sulphatase inhibitors
12/12/2000US6159942 Administering a pentose to increase energy
12/12/2000US6159937 Immunomodulators
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159704 Phosphatase modulator
12/12/2000US6159700 Method of finding agonist and antagonist to human and rat GPR14
12/12/2000US6159697 Antisense modulation of Smad7 expression
12/12/2000US6159694 Antisense modulation of stat3 expression
12/12/2000US6159485 Cosmetics; skin disorders
12/12/2000US6159468 Activated protein C formulations
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000US6159458 Sustained release ophthalmic compositions containing water soluble medicaments
12/12/2000US6159456 Photoprotective/cosmetic compositions comprising camphorsulfonic acid and bisresorcinyltriazine sunscreens
12/12/2000US6159450 Use of Ginkgo biloba flavonoidic extract substantially devoid of terpenes for oral hygiene and composition containing such extract
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000CA2186867C Methods of using iron chelating compounds to reduce free radical damage in mammals
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/12/2000CA2167397C Indoles
12/12/2000CA2063417C Antiviral composition
12/12/2000CA2058560C Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
12/09/2000CA2308691A1 Live attenuated bacteria for use in a vaccine
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000WO2000073477A1 Methods for induction of tolerance to adenoviral vectors and transgene products
12/07/2000WO2000073471A1 Cationic lipids for gene transfer and preparation method thereof
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073340A1 C-cam as an angiogenesis inhibitor
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073330A2 Method and compositions relating to insulin resistance disorders
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073316A2 Virus immunologic determinants
12/07/2000WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000WO2000073306A1 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
12/07/2000WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000WO2000073302A1 Oxazaheterocycles as protease inhibitors
12/07/2000WO2000073297A1 Substituted indolinone as tyrosine kinase inhibitors
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000WO2000073266A1 Novel antioxidants, preparation methods and uses
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072872A1 Keratinocyte growth factor-2 formulations
12/07/2000WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000WO2000072867A2 Substantially oil-free cyclosporin compositions
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000WO2000072856A1 Fibrin sealants providing less inflammatory response and methods using same
12/07/2000WO2000072849A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000WO2000072846A1 Antibacterial compounds
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072844A1 Neuronal death inhibitors
12/07/2000WO2000072842A1 Nutritional supplements
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072833A2 Pharmaceutical preparations for inhibiting sphingomyelinase
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000WO2000072742A2 Methods and materials for generating sh3 domains with tailored binding properties
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE
12/07/2000WO2000049937A3 Trpm-2 antisense therapy
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000046224A3 Tricyclic pyridine n-oxides vasopressin agonists
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000037141A9 Combination chemotherapy
12/07/2000WO2000035443A9 Method and composition for the maintenance and restitution of gut integrity
12/07/2000WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives
12/07/2000WO2000024390A9 Method and composition for modulating amyloidosis
12/07/2000DE19924148A1 Sphingomyelinasehemmer Sphingomyelinasehemmer
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375850A1 Method and compositions relating to insulin resistance disorders
12/07/2000CA2375829A1 Keratinocyte growth factor-2 formulations
12/07/2000CA2375826A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000CA2375630A1 Antibacterial compounds
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000CA2375123A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374990A1 C-cam as an angiogenesis inhibitor
12/07/2000CA2374921A1 Neuronal death inhibitors
1 ... 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 ... 1564